Octean Pharma ApS: Financial statements 2022
CVR: 38023667
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Octean Pharma ApS (CVR 38023667) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 571,137 and a net result of DKK 10,685 compared with DKK 42,977 the year before. That is a decrease of 52.1% compared with the year before. Equity in the 2022 report amounted to DKK 100,839. The solvency ratio was 11.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 571,137
- Profit/Loss
- DKK 10,685
- Equity
- DKK 100,839
- Total Assets
- DKK 853,609
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 571 t. | 11 t. | 101 t. | 1 |
| 2021 | - | 1.2 mio. | 43 t. | 90 t. | 1 |
| 2020 | 1.3 mio. | 793 t. | 11 t. | 47 t. | 1 |
| 2019 | 1.1 mio. | 751 t. | 51 t. | 36 t. | - |
| 2018 | 844 t. | 584 t. | 97 t. | -15 t. | - |
Official annual report
Keep an eye on Octean Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Octean Pharma ApS has published its annual report for 2021. Gross profit came to DKK 1,193,102, and the net result was DKK 42,977.
About Octean Pharma ApS
Octean Pharma ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 2016. The company is registered under the industry Detailhandel med andre fødevarer. The management consists of Lotte Johannesson. The company is owned by Halobid Aktiebolag. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -14,152 and a net result of DKK -15,398 compared with DKK 102,485 the year before. Equity in the 2025 report amounted to DKK 206,750.